The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Blood-brain barrier transport machineries and targeted therapy of brain diseases
Open accessAbstract
Introduction: Desired clinical outcome of pharmacotherapy of brain diseases largely depends upon the safe drug delivery into the brain parenchyma. However, due to the robust blockade function of the blood-brain barrier (BBB), drug transport into the brain is selectively controlled by the BBB formed by brain capillary endothelial cells and supported by astrocytes and pericytes. Methods: In the current study, we have reviewed the most recent literature on the subject to provide an insight upon the role and impacts of BBB on brain drug delivery and targeting. Results: All drugs, either small molecules or macromolecules, designated to treat brain diseases must adequately cross the BBB to provide their therapeutic properties on biological targets within the central nervous system (CNS). However, most of these pharmaceuticals do not sufficiently penetrate into CNS, failing to meet the intended therapeutic outcomes. Most lipophilic drugs capable of penetrating BBB are prone to the efflux functionality of BBB. In contrast, all hydrophilic drugs are facing severe infiltration blockage imposed by the tight cellular junctions of the BBB. Hence, a number of strategies have been devised to improve the efficiency of brain drug delivery and targeted therapy of CNS disorders using multimodal nanosystems (NSs). Conclusion: In order to improve the therapeutic outcomes of CNS drug transfer and targeted delivery, the discriminatory permeability of BBB needs to be taken under control. The carrier-mediated transport machineries of brain capillary endothelial cells (BCECs) can be exploited for the discovery, development and delivery of small molecules into the brain. Further, the receptor-mediated transport systems can be recruited for the delivery of macromolecular biologics and multimodal NSs into the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Caveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 987
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Yanagida, O., Kanai, Y., Chairoungdua, A., Kim, D. K., Segawa, H., Nii, T., Cha, S. H., Matsuo, H., Fukushima, J.-I., Fukasawa, Y., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00384-4 · Cited by 746
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Segawa, H., Fukasawa, Y., Miyamoto, K.-I., Takeda, E., Endou, H., & Kanai, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19745 · Cited by 498
Selective expression of the large neutral amino acid transporter at the blood–brain barrier
Boado, R. J., Li, J. Y., Nagaya, M., Zhang, C., & Pardridge, W. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12079 · Cited by 481
Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids
Oldendorf, W. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.6.1450 · Cited by 463
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier
Seidner, G., Alvarez, M. G., Yeh, J.-I., O'Driscoll, K. R., Klepper, J., Stump, T. S., Wang, D., Spinner, N. B., Birnbaum, M. J., & De Vivo, D. C. (1998) · Nature Genetics · doi:10.1038/ng0298-188 · Cited by 386
Cui, Y., Xu, Q., Chow, P. K.-H., Wang, D., & Wang, C.-H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.075 · Cited by 376
LAT2, a New Basolateral 4F2hc/CD98-associated Amino Acid Transporter of Kidney and Intestine
Rossier, G., Meier, C., Bauch, C., Summa, V., Sordat, B., Verrey, F., & Kühn, L. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34948 · Cited by 363
Function and structure of heterodimeric amino acid transporters
Wagner, C. A., Lang, F., & Bröer, S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.4.c1077 · Cited by 357
Mutations in ABCA12 Underlie the Severe Congenital Skin Disease Harlequin Ichthyosis
David Kelsell, P., Elizabeth Norgett, E., Unsworth, H., Teh, M.-T., Cullup, T., Mein, C. A., Patricia Dopping-Hepenstal, J., Beverly Dale, A., Tadini, G., Fleckman, P., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429844 · Cited by 351
Multifunctional nanoparticles for brain tumor imaging and therapy
Cheng, Y., Morshed, R. A., Auffinger, B., Tobias, A. L., & Lesniak, M. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.006 · Cited by 349
de Boer, A. G., & Gaillard, P. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 348
Halestrap, A. P. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c130008 · Cited by 339
Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma
Grapp, M., Wrede, A., Schweizer, M., Hüwel, S., Galla, H.-J., Snaidero, N., Simons, M., Bückers, J., Low, P. S., Urlaub, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3123 · Cited by 334
Transfer of glutamine between astrocytes and neurons
Bröer, S., & Brookes, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00322.x · Cited by 325
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3246 · Cited by 324
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
del Amo, E. M., Urtti, A., & Yliperttula, M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.015 · Cited by 319
Aktaş, Y., Yemisci, M., Andrieux, K., Gürsoy, R. N., Alonso, M. J., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., Riguera, R., Sargon, M. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050217o · Cited by 318
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene
Torrents, D., Mykkänen, J., Pineda, M., Feliubadaló, L., Estévez, R., Cid, R. D., Sanjurjo, P., Zorzano, A., Nunes, V., Huoponen, K., et al. (1999) · Nature Genetics · doi:10.1038/6809 · Cited by 317
Activation of system L heterodimeric amino acid exchangers by intracellular substrates
Meier, C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.580 · Cited by 314
Transport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2
Sugawara, M., Huang, W., Fei, Y., Leibach, F. H., Ganapathy, V., & Ganapathy, M. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200006)89:6<781::aid-jps10>3.0.co;2-7 · Cited by 312
Strategies for transporting nanoparticles across the blood–brain barrier
Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308
Retinopathy in Mice Induced by Disrupted All-trans-retinal Clearance
Maeda, A., Maeda, T., Golczak, M., & Palczewski, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804505200 · Cited by 300
The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier
Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02758-x · Cited by 298
The blood-brain barrier and glutamate
Hawkins, R. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27462bb · Cited by 291
The role of glucose transporters in brain disease: Diabetes and Alzheimer’s disease
Shah, K., DeSilva, S., & Abbruscato, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012629 · Cited by 288
Gumbleton, M., & Audus, K. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1119 · Cited by 286
System L: heteromeric exchangers of large, neutral amino acids involved in directional transport
Verrey, F. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0973-z · Cited by 284
Clark, A. J., & Davis, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517048112 · Cited by 280
Seow, H. F., Bröer, S., Bröer, A., Bailey, C. G., Potter, S. J., Cavanaugh, J. A., & Rasko, J. E. J. (2004) · Nature Genetics · doi:10.1038/ng1406 · Cited by 277
Na+-dependent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain Barrier
O'Kane, R. L., Martı́nez-López, I., DeJoseph, M. R., Viña, J. R., & Hawkins, R. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31891 · Cited by 268
Expression of the neonatal Fc receptor (FcRn) at the blood–brain barrier
Schlachetzki, F., Zhu, C., & Pardridge, W. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00840.x · Cited by 265
Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26
Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264
Transport of cholesterol from the endoplasmic reticulum to the plasma membrane.
Kaplan, M. R., & Simoni, R. D. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.2.446 · Cited by 263
Exosomes are endogenous nanoparticles that can deliver biological information between cells
Sun, D., Zhuang, X., Zhang, S., Deng, Z.-B., Grizzle, W., Miller, D., & Zhang, H.-G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.002 · Cited by 250
Dick, A. P., Harik, S. I., Klip, A., & Walker, D. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7233 · Cited by 247
Omidi, Y., Campbell, L., Barar, J., Connell, D., Akhtar, S., & Gumbleton, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03443-7 · Cited by 246
Self-citationMorgello, S., Uson, R. R., Schwartz, E. J., & Haber, R. S. (1995) · Glia · doi:10.1002/glia.440140107 · Cited by 238
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
Zhang, B., Sun, X., Mei, H., Wang, Y., Liao, Z., Chen, J., Zhang, Q., Hu, Y., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.039 · Cited by 225
Molecular Biology of the Blood–Brain Barrier
Pardridge, W. M. (2005) · Molecular Biotechnology · doi:10.1385/mb:30:1:057 · Cited by 220
Late Endosomes: Sorting and Partitioning in Multivesicular Bodies
Piper, R. C., & Luzio, J. P. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.20904.x · Cited by 218
Schnitzer, J. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.1.h246 · Cited by 217
Cytotoxic Impacts of Linear and Branched Polyethylenimine Nanostructures in A431 Cells
Kafil, V., & Omidi, Y. (2011) · Tabriz University of Medical Sciences · doi:10.5681/bi.2011.004 · Cited by 215
Self-citationMiller, S. E., Mathiasen, S., Bright, N. A., Pierre, F., Kelly, B. T., Kladt, N., Schauss, A., Merrifield, C. J., Stamou, D., Höning, S., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.03.002 · Cited by 207
Intracellular transport of cholesterol to the plasma membrane.
DeGrella, R. F., & Simoni, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45374-x · Cited by 203
Exosomes and the Emerging Field of Exosome-Based Gene Therapy
O’Loughlin, A., Woffindale, C., & Wood, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802083594 · Cited by 193
Thyroid Hormone Transport by the Heterodimeric Human System L Amino Acid Transporter
Friesema, E. C. H., Docter, R., Moerings, E. P. C. M., Verrey, F., Krenning, E. P., HENNEMANN, G., & Visser, T. J. (2001) · Endocrinology · doi:10.1210/en.142.10.4339 · Cited by 188
Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies
Smith, M. W., & Gumbleton, M. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600650086 · Cited by 185
Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein
Vogel, S. M., Minshall, R. D., Pilipović, M., Tiruppathi, C., & Malik, A. B. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.6.l1512 · Cited by 184
Transcytosis of Macromolecules at the Blood–Brain Barrier
Preston, J. E., Joan Abbott, N., & Begley, D. J. (2014) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.06.001 · Cited by 182
Pérez de Heredia, F., Wood, I. S., & Trayhurn, P. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0750-3 · Cited by 179
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells
Kim, D. K., Kanai, Y., Choi, H. W., Tangtrongsup, S., Chairoungdua, A., Babu, E., Tachampa, K., Anzai, N., Iribe, Y., & Endou, H. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00516-3 · Cited by 175
Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy
Barar, J., & Omidi, Y. (2013) · PubMed · doi:10.5681/bi.2013.036 · Cited by 175
Self-citationCarrier-mediated or specialized transport of drugs across the blood–brain barrier
Tsuji, A., & Tamai, I. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00084-2 · Cited by 174
Ceballos, A., Belinchon, M. M., Sanchez-Mendoza, E., Grijota-Martinez, C., Dumitrescu, A. M., Refetoff, S., Morte, B., & Bernal, J. (2009) · Endocrinology · doi:10.1210/en.2008-1616 · Cited by 173
P-glycoprotein ABCB1: a major player in drug handling by mammals
Borst, P., & Schinkel, A. H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70430 · Cited by 167
Tang, S. C., Lagas, J. S., Lankheet, N. A. G., Poller, B., Hillebrand, M. J., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26000 · Cited by 165
Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity
Verrey, F., Meier, C., Rossier, G., & Kühn, L. C. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000274 · Cited by 162
Regulation of ABC transporters at the blood–brain barrier
Miller, D. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.64 · Cited by 160
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Zong, T., Mei, L., Gao, H., Cai, W., Zhu, P., Shi, K., Chen, J., Wang, Y., Gao, F., & He, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500057n · Cited by 160
Pardridge, W. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1042364 · Cited by 159
Advanced drug delivery and targeting technologies for the ocular diseases
Barar, J., Aghanejad, A., Fathi, M., & Omidi, Y. (2016) · Bioimpacts · doi:10.15171/bi.2016.07 · Cited by 155
Self-citationRoelse, J., Grommé, M., Momburg, F., Hämmerling, G. J., & Neefjes, J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1591 · Cited by 153
Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152
Self-citationExosomes and the blood–brain Barrier: Implications for Neurological Diseases
Wood, M. J. A., O’Loughlin, A. J., & Lakhal, S. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.83 · Cited by 148
Expression of a system L neutral amino acid transporter at the blood–brain barrier
Matsuo, H., Tsukada, S., Nakata, T., Chairoungdua, A., Kim, D. K., Ho, S., Inatomi, J., Yorifuji, H., Fukuda, J., Endou, H., et al. (2000) · Neuroreport · doi:10.1097/00001756-200011090-00021 · Cited by 147
Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7
Sanovich, E. Y., Bartus, R. T., Friden, P. M., Dean, R. L., Le, H. Q., & Brightman, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01143-9 · Cited by 142
Rosilio, C., Nebout, M., Imbert, V., Griessinger, E., Neffati, Z., Benadiba, J., Hagenbeek, T. J., Spits, H., Reverso, J., Ambrosetti, D., et al. (2014) · Leukemia · doi:10.1038/leu.2014.338 · Cited by 140
Chen, G., Fang, Q., Zhang, J., Zhou, D., & Wang, Z. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22577 · Cited by 138
Wei, L., Guo, X., Yang, T., Yu, M., Chen, D., & Wang, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.127 · Cited by 138
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Miranda‐Gonçalves, V., Granja, S., Martinho, O., Honavar, M., Pojo, M., Costa, B. M., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10114 · Cited by 136
Identification of the Cationic Amino Acid Transporter (System y+) of the Rat Blood‐Brain Barrier
Stoll, J., Wadhwani, K. C., & Smith, Q. R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13428.x · Cited by 130
Katt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152105 · Cited by 129
Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn
Cooper, P. R., Ciambrone, G. J., Kliwinski, C. M., Maze, E., Johnson, L., Li, Q., Feng, Y., & Hornby, P. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.035 · Cited by 127
Therapeutic Nanomedicine for Brain Cancer
Tzeng, S. Y., & Green, J. J. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.38 · Cited by 124
Ose, A., Ito, M., Kusuhara, H., Yamatsugu, K., Kanai, M., Shibasaki, M., Hosokawa, M., Schuetz, J. D., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024018 · Cited by 124
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
Omidi, Y., & Barar, J. (2014) · PubMed Central · doi:10.5681/bi.2014.021 · Cited by 123
Self-citationHan, L., Kong, D. K., Zheng, M.-Q., Murikinati, S., Ma, C., Yuan, P., Li, L., Tian, D., Cai, Q., Ye, C., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07573 · Cited by 122
Su, Z., Xing, L., Chen, Y., Xu, Y., Yang, F., Zhang, C., Ping, Q. N., & Xiao, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500238m · Cited by 115
Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+
O’Kane, R. L., Vinã, J. R., Simpson, I. A., Zaragozá, R., Mokashi, A. S., & Hawkins, R. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00007.2006 · Cited by 109
Bröer, S. (2009) · IUBMB Life · doi:10.1002/iub.210 · Cited by 107
Primary and secondary thyroid hormone transporters
Kinne, A., Schülein, R., & Krause, G. (2011) · Thyroid Research · doi:10.1186/1756-6614-4-s1-s7 · Cited by 107
Dolgodilina, E., Imobersteg, S., Laczkó, E., Welt, T., Verrey, F., & Makrides, V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15609331 · Cited by 101
OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma
Yue, P.-J., He, L., Qiu, S.-W., Li, Y., Liao, Y.-J., LI, X.-P., Xie, D., & Peng, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-191 · Cited by 99
Na+- and Cl−-Dependent transport of taurine at the blood-brain barrier
Tamai, I., Senmaru, M., Terasaki, T., & Tsuji, A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02046-2 · Cited by 93
Zhu, J., Zhou, K., Hao, J.-J., Liu, J., Smith, N., & Zhan, X. (2005) · Journal of Cell Science · doi:10.1242/jcs.01668 · Cited by 93
Monsalve, Y., Tosi, G., Ruozi, B., Belletti, D., Vilella, A., Zoli, M., Vandelli, M. A., Forni, F., López, B. L., & Sierra, L. (2015) · Nanomedicine · doi:10.2217/nnm.15.29 · Cited by 93
Brain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier
Mantych, G. J., James, D. E., & Devaskar, S. U. (1993) · Endocrinology · doi:10.1210/endo.132.1.8419132 · Cited by 91
From uncertain beginnings: Initiation mechanisms of clathrin-mediated endocytosis
Godlee, C., & Kaksonen, M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201307100 · Cited by 90
Kanai, Y., & Endou, H. (2003) · The Journal of Toxicological Sciences · doi:10.2131/jts.28.1 · Cited by 90
Wang, L., Hao, Y., Li, H., Zhao, Y., Meng, D., Li, D., Shi, J., Zhang, H., Zhang, Z., & Zhang, Y. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1025077 · Cited by 89
Toxicogenomics of Cationic Lipid-based Vectors for Gene Therapy: Impact of Microarray Technology
Omidi, Y., Barar, J., & Akhtar, S. (2005) · Current Drug Delivery · doi:10.2174/156720105774370249 · Cited by 89
Self-citationCabezón, I., Manich, G., Martín-Venegas, R., Camins, A., Pelegrí, C., & Vilaplana, J. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00597 · Cited by 89
Patil, R., Ljubimov, A. V., Gangalum, P. R., Ding, H., Portilla‐Arias, J., Wagner, S. R., Inoue, S., Konda, B. M., Rekechenetskiy, A., Chesnokova, A., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01872 · Cited by 88
Kido, Y., Tamai, I., Uchino, H., Suzuki, F., Sai, Y., & Tsuji, A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775794 · Cited by 88
Fan, X., Ross, D. D., Arakawa, H., Ganapathy, V., Tamai, I., & Nakanishi, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.021 · Cited by 85
Sodium-Proton (Na+/H+) Antiporters: Properties and Roles in Health and Disease
Padan, E., & Landau, M. (2016) · Metal ions in life sciences · doi:10.1007/978-3-319-21756-7_12 · Cited by 84
Eilers, M., Roy, U. B., & Mondal, D. (2008) · Experimental Biology and Medicine · doi:10.3181/0802-rm-59 · Cited by 82
Gao, H., Yang, Z. H., Zhang, S., Pang, Z., Liu, Q., & Jiang, X. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.11.003 · Cited by 79
Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.
Adkison, K. D. K., & Shen, D. D. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12397-5 · Cited by 78
Smith, M. W., Omidi, Y., & Gumbleton, M. (2007) · Journal of drug targeting · doi:10.1080/10611860701288539 · Cited by 78
Self-citationLam, T. I., Wise, P. M., & O’Donnell, M. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00093.2009 · Cited by 78
Boleti, H., Coe, I. R., Baldwin, S. A., Young, J. D., & Cass, C. E. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00136-6 · Cited by 77
Liu, Z., Zhao, H., Shu, L., Zhang, Y., Okeke, C. I., Zhang, L., Li, J., & Li, N. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.861478 · Cited by 76
Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1
Näßl, A., Rubio‐Aliaga, I., Fenselau, H., Marth, M. K., Kottra, G., & Daniel, H. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2011 · Cited by 76
BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS
Peluffo, H., Unzueta, U., Negro‐Demontel, M. L., Xu, Z., Váquez, E., Ferrer‐Miralles, N., & Villaverde, A. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.004 · Cited by 75
Easton, A. S., & Abbott, N. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03281-x · Cited by 74
Nii, T., Segawa, H., Taketani, Y., Tani, Y., OHKIDO, M., KISHIDA, S., Ito, M., Endou, H., Kanai, Y., Takeda, E., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580693 · Cited by 74
Clathrin-Mediated Endocytosis and Adaptor Proteins
Popova, N. V., Deyev, I. E., & Petrenko, A. G. (2013) · Acta Naturae · doi:10.32607/20758251-2013-5-3-62-73 · Cited by 72
Huttunen, K. M., Gynther, M., Huttunen, J., Puris, E., Spicer, J. A., & Denny, W. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00190 · Cited by 72
Omidi, Y., Barar, J., Heidari, H. R., Ahmadian, S., Yazdi, H. A., & Akhtar, S. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510801891286 · Cited by 70
Self-citationTaurine transport at the blood-brain barrier: an in vivo brain perfusion study
Benrabh, H., Bourre, J. M., & Lefauconnier, J.-M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00648-a · Cited by 70
BSA Nanoparticle Loaded Atorvastatin Calcium - A New Facet for an Old Drug
Sripriyalakshmi, S., H, A. C., Doss, C. G. P., Rajith, B., & Ravindran, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086317 · Cited by 68
Impacts of Blood-Brain Barrier in Drug Delivery and Targeting of Brain Tumors
Omidi, Y., & Barar, J. (2012) · Europe PMC (PubMed Central) · doi:10.5681/bi.2012.002 · Cited by 68
Self-citationIon transporters in brain endothelial cells that contribute to formation of brain interstitial fluid
Mokgokong, R., Wang, S., Taylor, C. J., Barrand, M. A., & Hladky, S. B. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1342-9 · Cited by 67
Ylikangas, H., Malmioja, K., Peura, L., Gynther, M., Nwachukwu, E. O., Leppänen, J., Laine, K., Rautio, J., Lahtela-Kakkonen, M. K., Huttunen, K. M., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402281 · Cited by 66
Characterization of alpha-keto acid transport across blood-brain barrier in rats
Conn, A. R., Fell, D. I., & Steele, R. D. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.245.3.e253 · Cited by 65
Mechanisms of Glutamate Efflux at the Blood—Brain Barrier: Involvement of Glial Cells
Malina, K. C.-K., Cooper, I., & Teichberg, V. I. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.121 · Cited by 63
Hosoya, K., Tomi, M., Ohtsuki, S., Takanaga, H., Saeki, S., Kanai, Y., Endou, H., Naito, M., Tsuruo, T., & Terasaki, T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.225 · Cited by 63
Osmotic opening the blood‐brain barrier
Rapoport, S. I. (1988) · Annals of Neurology · doi:10.1002/ana.410240513 · Cited by 62
Liu, Z., Zhang, L., He, Q., Liu, X., Chukwunweike Ikechukwu, O., Tong, L., Guo, L., Yang, H., Zhang, Q., Zhao, H., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.049 · Cited by 62
Membrane traffic to and from lysosomes.
Luzio, J. P., Pryor, P. R., Gray, S. R., Gratian, M. J., Piper, R. C., & Bright, N. A. (2005) · Biochemical Society Symposia · doi:10.1042/bss0720077 · Cited by 61
Mutations in the Cholesterol Transporter Gene ABCA5 Are Associated with Excessive Hair Overgrowth
DeStefano, G. M., Kurban, M., Anyane‐Yeboa, K., Dall’Armi, C., Paolo, G. D., Feenstra, H., Silverberg, N. B., Rohena, L. O., López-Cepeda, L. D., Jobanputra, V., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004333 · Cited by 59
Receptor-Mediated Therapeutic Transport Across the Blood–Brain Barrier
Wang, Y., Lui, P. C. W., & Li, J. Y. (2009) · Immunotherapy · doi:10.2217/imt.09.75 · Cited by 59
Nicolazzo, J. A., & Katneni, K. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521580 · Cited by 57
Hoffmann, K., Gastens, A. M., Volk, H. A., & Löscher, W. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.12.005 · Cited by 56
Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cells
Bohmer, N., & Jordan, A. (2015) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.6.16 · Cited by 55
Can Leptin-Derived Sequence-Modified Nanoparticles Be Suitable Tools for Brain Delivery?
Tosi, G., Badiali, L., Ruozi, B., Vergoni, A. V., Bondioli, L., Ferrari, A., Rivasi, F., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.98 · Cited by 52
The Spatial Organization of Proton and Lactate Transport in a Rat Brain Tumor
Grillon, E., Farion, R., Fablet, K., WAARD, M. M. D., Tse, C., Donowitz, M., Rémy, C., & Coles, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017416 · Cited by 51
Acute upregulation of blood-brain barrier glucose transporter activity in seizures
Cornford, E. M., Nguyen, E. V., & Landaw, E. M. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1346 · Cited by 51
Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways
Hwang, M. E., Keswani, R. K., & Pack, D. W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1598-6 · Cited by 50
LAT1-mediated Prodrug Uptake: a Way to Breach the blood–brain barrier?
Rautio, J., Gynther, M., & Laine, K. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.165 · Cited by 49
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains
Bröer, A., Friedrich, B., Wagner, C. A., Fillon, S., Ganapathy, V., Lang, F. J. W., & Bröer, S. (2001) · Biochemical Journal · doi:10.1042/bj3550725 · Cited by 49
Young Sook, K. A. N. G., Terasaki, T., Ohnishi, T., & Tsuji, A. (1990) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.13.353 · Cited by 48
Caveolae: molecular insights and therapeutic targets for stroke
Xu, L., Guo, R., Xie, Y., Ma, M., Ye, R., & Liu, X. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1009446 · Cited by 48
Miller, L. P., & Oldendorf, W. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01756.x · Cited by 46
Nucleoside Transporters: Biological Insights And Therapeutic Applications
Choi, J.-S., & Berdis, A. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.79 · Cited by 45
Wagner, C. A., Bröer, A., Albers, A., Gamper, N. L., Lang, F., & Bröer, S. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00035.x · Cited by 45
Herck, S. L. J. V., Delbaere, J., Bourgeois, N. M. A., McAllan, B. M., Richardson, S. J., & Darras, V. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.02.021 · Cited by 44
Bao, H., Jin, X., Li, L., Lv, F., & Liu, T. (2012) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-012-4658-7 · Cited by 42
Targeting caveolae for vesicular drug transport
Gumbleton, M., Hollins, A. J., Omidi, Y., Campbell, L., & Taylor, G. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00358-9 · Cited by 42
Self-citationGlutamate is transported across the rat blood-brain barrier by a sodium-independent system
Benrabh, H., & Lefauconnier, J.-M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12635-5 · Cited by 41
Monoclonal antibodies directed against human FcRn and their applications
Christianson, G. J., Sun, V. Z., Akilesh, S., Pesavento, E., Proetzel, G., & Roopenian, D. C. (2012) · mAbs · doi:10.4161/mabs.4.2.19397 · Cited by 40
Omidi, Y., Barar, J., Ahmadian, S., Heidari, H. R., & Gumbleton, M. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1455 · Cited by 40
Self-citationProdrug Design Targeting Intestinal PepT1 for Improved Oral Absorption: Design and Performance
Zhang, Y., Sun, J., Sun, Y., Wang, Y., & He, Z. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314060004 · Cited by 38
Effects of diabetes on brain metabolism – is brain glycogen a significant player?
Sickmann, H. M., & Waagepetersen, H. S. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9546-z · Cited by 37
Tissue selective drug delivery utilizing carrier-mediated transport systems
Tsuji, A. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00043-7 · Cited by 35
Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles
Gao, H., Yang, Z. H., Zhang, S., Pang, Z., & Jiang, X. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.886038 · Cited by 34
Ma, H., Gao, Z., Yu, P., Shen, S., Liu, Y., & Xu, B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.148 · Cited by 31
Kaira, K., Arakawa, K., Shimizu, K., Oriuchi, N., Nagamori, S., Kanai, Y., Oyama, T., & Takeyoshi, I. (2015) · PubMed Central · Cited by 27
Functional characterization of tyrosine transport in fibroblast cells from healthy controls
Vumma, R., Wiesel, F., Flyckt, L., Bjerkenstedt, L., & Venizelos, N. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.028 · Cited by 25
Powell, T. R., Tansey, K. E., Breen, G. D., FARMER, A. E., Craig, I., Uher, R., McGuffin, P., D’Souza, U. M., & Schalkwyk, L. C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113490329 · Cited by 24
Mutations in the ABCA3 Gene Are Associated With Cataract-Microcornea Syndrome
Chen, P., Dai, Y., Wu, X., Wang, Y., Sun, S., Xiao, J., Zhang, Q., Guan, L., Zhao, X., Hao, X., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14098 · Cited by 23
Sakaeda, T., Siahaan, T. J., Audus, K. L., & Stella, V. J. (2000) · Journal of drug targeting · doi:10.3109/10611860008996865 · Cited by 23
Barrier functionality and transport machineries of human ECV304 cells.
Barar, J., Gumbleton, M., Asadi, M., & Omidi, Y. (2010) · PubMed · Cited by 21
Self-citationABC1:The Gene for Tangier Disease and Beyond
Ordovás, J. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2000.tb01843.x · Cited by 20
A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
Rafi, M. A., & Omidi, Y. (2015) · Bioimpacts · doi:10.15171/bi.2015.22 · Cited by 19
Self-citationImaging In Vivo Astrocyte/Endothelial Cell Interactions at the Blood–Brain Barrier
Willis, C. L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-452-0_34 · Cited by 19
Barrier Functionality of Porcine and Bovine Brain Capillary Endothelial Cells
Nakhlband, A., & Omidi, Y. (2011) · Europe PMC (PubMed Central) · doi:10.5681/bi.2011.021 · Cited by 18
Self-citationTsuji, A., & Tamai, I. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-46812-3_16 · Cited by 18
Brain‐to‐blood active transport of β‐alanine across the blood–brain barrier
Komura, J., Tamai, I., Senmaru, M., Terasaki, T., Sai, Y., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01366-x · Cited by 17
Caram‐Salas, N. L., Boileau, E., Farrington, G. K., Garber, E. A., Brunette, E., Abulrob, A., & Stanimirovic, D. B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-191-8_26 · Cited by 17
Osmotic Opening of the Blood‐Brain Barrier
Rapoport, S. I. (1978) · Novartis Foundation symposium · doi:10.1002/9780470720370.ch13 · Cited by 16
Liu, Y.-H., Chen, Y.-J., Wu, H., Wang, T.-Y., & Tsai, F. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.027 · Cited by 16
Targeting of cytosolic proteins to lysosomes for degradation.
Dice, J. F., & Terlecky, S. R. (1990) · PubMed · Cited by 16
Interaction of Nucleoside Analogues with Nucleoside Transporters in Rat Brain Endothelial Cells
Chishty, M., Begley, D. J., Abbott, N. J., & Reichel, A. (2004) · Journal of drug targeting · doi:10.1080/10611860410001731398 · Cited by 12
Rautio, J., Kärkkäinen, J., Huttunen, K. M., & Gynther, M. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.09.025 · Cited by 12
Caveolae-mediated membrane transport
Gumbleton, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00137-5 · Cited by 7
Smythe, E. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2569-8_24 · Cited by 4
Cited by
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Pulgar, V. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01019 · Cited by 482
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., Silva, F., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 381
Boron neutron capture therapy: Current status and future perspectives
Dymova, M. A., Taskaev, S. Y., Richter, V. A., & Kuligina, E. V. (2020) · Cancer Communications · doi:10.1002/cac2.12089 · Cited by 339
Blood-Brain Delivery Methods Using Nanotechnology
Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040269 · Cited by 305
Engineered human blood–brain barrier microfluidic model for vascular permeability analyses
Hajal, C., Offeddu, G. S., Shin, Y., Zhang, S., Morozova, O., Hickman, D., Knutson, C. G., & Kamm, R. D. (2022) · Nature Protocols · doi:10.1038/s41596-021-00635-w · Cited by 257
Metadata
- Authors
- Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y.
- Venue
- BioImpacts
- Publisher
- Maad Rayan Publishing Company
- Published
- 2016-12-05
- Volume
- 6
- Issue
- 4
- Pages
- 225-248
- ISSN
- 2228-5652 (ISSN-L)
- 2228-5660
- OpenAlex
- W2595999211
- Cited by
- 257
- References
- 185
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.